Andrew John.William Heath, Director at Shield Therapeutics, holds 89.05K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Andrew John.William Heath Bought 3,334p shares of Shield Therapeutics on Jun 15, 2017 for an estimated value of 5.00K.
What is the percentage of profitable transactions made by Andrew John.William Heath?
The percentage of profitable transactions made by Andrew John.William Heath is ―.
What is the average return per transaction made by Andrew John.William Heath?
The average return per transaction made by Andrew John.William Heath is ―.
What stocks does Andrew John.William Heath hold?
Andrew John.William Heath holds: GB:STX stocks.
What was Andrew John.William Heath’s latest transaction?
Andrew John.William Heath latest transaction was an Informative Buy of 5.00K.
What was Andrew John.William Heath's most profitable transaction?
Andrew John.William Heath’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew John.William Heath's role in Shield Therapeutics?
Andrew John.William Heath's role in Shield Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.